Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function

Nephrology Dialysis Transplantation

Volumn 15, Issue 5, 2000, Pages 637-643

  Van Paassen, Pieter ^a   De Zeeuw, Dick ^a   Navis, Gerjan ^a   De Jong, Paul E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Chronic renal failure; Hypertension; Proteinuria; Renal haemodynamics; Renin inhibition

Indexed keywords

ALBUMIN; POTASSIUM; REMIKIREN; RENIN INHIBITOR; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; LONGITUDINAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POTASSIUM BALANCE; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; SINGLE BLIND PROCEDURE; SODIUM BALANCE; SODIUM URINE LEVEL; VASODILATATION;

EID: 0034050578     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.5.637     Document Type: Article

References (30)

1. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945
2. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
3. Gansevoort RT, Zeeuw D de, Jong PE de. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994; 45: 861-867
4. Azizi M, Guyene TT, Chalellier G, Menard J. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension. J Hypertens 1994; 12: 419-427
5. Neutel JM, Luther RR, Boger RS, Weber MA. Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat. Am Heart J 1991; 122: 1094-1000
6. van den Meiracker AH, Admiraal PJJ, Derkx FHM et al. Comparison of blood pressure and angiotensin responses to the renin inhibitor RO 42 5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. J Hypertens 1993; 11: 831-838
7. Jeunemaitre X, Menard J, Nussberger J, Guyene TT, Brunner HR, Corvol P. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560 A in hypertensive patients. Am J Hypertens 1989; 2: 819-827
8. van de Meiracker AH, Admiraal PJJ, Man in't Veld AJ et al. Prolonged blood pressure reduction by orally active renin inhibitor RO 42 5892 in essential hypertension. Br Med J 1990; 301: 205-210
9. Kobrin I, Viskoper RJ, Laszt A, Bock J, Weber C, Charlon V. Effects of an orally active renin inhibitor RO 42-5892 in patients with essential hypertension. Am J Hypertens 1993; 6: 349-356
10. Viskoper RJ, Charlon V, Laszt A et al. Time dependency of the antihypertensive efficacy of the new renin inhibitor RO 42 5892. J Hum Hypertens 1994; 8: 133-136
11. van Paassen P, de Zeeuw D, de Jong PE. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension. J Cardiovasc Pharmacol 1995: 26: 39-45
12. Cordero P, Fisher ND, Moore TJ, Gleason R, Williams GH, Hollenberg NK. Renal and endocrine responses to a renin inhibitor, enalkiren in normal humans. Hypertension 1991; 17: 510-517
13. Fisher NDL, Allan D, Kifor I et al. Responses to converting enzyme and renin inhibition: role of angiotensin in humans. Hypertension 1994; 23: 44-51
14. Fisher NDL, Hollenberg NK. Renal vascular responses to renin inhibition with zankiren in man. Clin Pharmacol Ther 1995; 57: 342-348
15. Smith SG III, Seymour AA, Mazack EK, Boger J, Blame EH. Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs. Hypertension 1987; 9: 150-156
16. El Amrani AIK, Menard J, Gonzalez MF, Michel JB. Effects of blocking the angiotensin II receptor, converting enzyme and renin activity on the renal hemodynamics of normotensive guinea pigs. J Cardiovasc Pharmacol 1993; 22: 231-239
17. Hollenberg NK, Fisher NDL. Renal circulation and blockade of the renin-angiotensin system. Is angiotensin converting enzyme the last word? Hypertension 1995; 26: 602-609
18. Cumin F, De Gasparo M, Wood JM, Schnell C, Frueh F, Graf P. Assays to measure nanomolar levels of the renin inhibitor CGP 38-560 in plasma. Hypertension 1989; 14: 379-384
19. Donker AJM, van der Hem GK, Sluiter WJ, Beekhuis H. A radioisotope method for simultaneous determination of the glomerular filtration rate and effective renal plasma flow. Neth J Med 1977; 20: 97-103
20. Derkex FHM, van den Meiracker AH, Fischli W et al. Nonparallel effects of renin inhibitor treatment on PRA and Ang I and Ang II in hypertensive subjects. Am J Hypertens 1991; 4: 602-609
21. Clozel JP, Fischli W. Comparative effects of three different potent renin inhibitors. Hypertension 1993; 22: 9-17
22. Coassolo Ph, Fischli W, Clozel JP, Chou RC. Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates. Xenobiotica 1996; 26: 333-345
23. Richter WF, Whitby BR, Chou RC. Distribution of remikiren, a potent orally active inhibitor of human renin in laboratory animals. Xenobiotica 1996: 26: 243-254
24. Navis GJ, Jong PE de, Donker AJM, Hem GK van der, Zeeuw D de. Diuretic effects of ACE-inhibition; comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol 1987; 9: 743-748
25. Navis GJ, de Jong PE, Donker AJM, de Zeeuw D. Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension. Proc EDTA 1983; 20: 577-581
26. Apperloo AJ, de Zeeuw D, de Jong PE. A short-term antihypertensive treatment induced fall in glomerular filtration rate predicts long term stability of renal function. Kidney Int 1997; 51: 793-797
27. Gansevoort RT, de Zeeuw D, de Jong PE. Long-term benefits of the antiproteinuric effect of ACE-inhibition in non-diabetic renal disease. Am J Kidney Dis 1993; 2: 202-206
28. Hollenberg NK, Fisher ND, Price DA. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological intervention in the renin system. Hypertension 1998; 32: 387-392
29. Gansevoort RT, Zeeuw D de, Jong PE de. Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin-I converting enzyme inhibition. Kidney Int 1993; 44: 579-584
30. Fossa AA, Weinberg LJ, Barber RL et al. Synergistic effect on reduction in blood pressure with co-administration of the renin inhibitor CP 80,794 and the angiotensin conveting enzyme inhibitor captopril. J Cardiovasc Pharmacol 1992; 20: 75-82